ArticleMolecular cancer therapeutics2020

A Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma.

Marina Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.